Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

UK private dentistry could face CMA review over price transparency

UK Chancellor Rachel Reeves has called on the Competition and Markets Authority (CMA), the principal competition regulator in the UK, to launch an investigation into the country’s private dentistry sector, citing concerns over “hidden costs, lack of transparency and overtreatment.”  Letters released by the government reveal that Reeves has asked the regulator to examine how effectively competition operates among private providers and whether patients receive genuine choice and value for money.

FREE BLOG Thoughts on digital health

Last week we published a Special Report on digital health. This is the first time we’ve published an in-depth report on this topic, but most likely won’t be the last. The report looks at the major avenues and frontiers of innovation in healthcare’s digital revolution, and includes case study interviews of eight different digital health […]

Increasing demand for GLP-1 drugs driving supply chain consolidation by big pharma

GLP-1s are no longer regarded as “breakthrough treatments"; they are now seen as routine treatments for the management of chronic conditions. The rising demand for GLP-1s has also created pressure on supply chains, prompting increased investment in manufacturing and distribution, and vertical integration by major pharmaceutical companies — something that was highlighted by many speakers at the Jefferies London Healthcare Conference this week. 

Siemens mulls reducing Healthineers stake to minority, Siemens Healthineers continues to mull diagnostics unit sale

German multinational medtech firm Siemens Healthineers is reviewing strategic options for its diagnostics division, including a possible sale. The company stated that its laboratory unit, which supplies a range of technologies to diagnostic labs including equipment and reagents, is being developed under several scenarios and may no longer be the best fit within the group.

Circio looking for partners to help bring circular RNA gene therapy technology to market

Circio, a pre-clinical biotech company that is listed on the Oslo stock exchange, has developed a form of RNA technology that, if successful, could make cell and gene therapy much safer, more effective and more economic, and therefore available to a wide population. HBI sat down with Lubor Gaal, the company’s CFO, at Jefferies’ Global Healthcare Conference in London this week, to understand a bit more about the technology and what the company needs to get to market.

Kooth continues US expansion with Kismet acquisition

UK-based listed digital mental healthcare group Kooth is continuing its expansion into the US market with the acquisition of Kismet, a small US digital mental healthcare company that specialises in under 12s. Kooth’s CEO Kate Newhouse tells us the acquisition will expand the capabilities and reach of Kooth’s US platform Soluna.

Find Us